UltraPlex
UltraPlex pioneering sustainable and cost-efficient liposome-based RNA therapeutics delivery.
Status:
Pre-business
SDGs:
Good health and well-being
Industry:
Life science and medical
Impact:
Quality of life
Origin:
Research to Business
School:
School of Science
Established:
2025
The UltraPlex project develops a next-generation liposome-based drug delivery system for RNA therapeutics that is sustainable, cost-efficient, and scalable for pharmaceutical applications. Traditional liposomal formulations face challenges such as high production costs, solvent dependency, material waste, and therapeutic molecule encapsulation inefficiency issues, limiting their commercial viability. UltraPlex addresses these challenges by integrating green chemistry, nanotechnology, and focused ultrasound principles to create an eco-friendly and efficient drug delivery platform.
Contact
Christopher Fogarty
Business Developer
Read more about innovation services
News from innovation ecosystem
The company established by three anthropologists relied on strong research expertise
Etnografinen tutkimustoimisto Kenno Oy was established in 2014 when its three founders were finalising their master's degree studies at the University of Helsinki and wanted to create an interesting job for themselves.
The idea of three researchers generated a deep tech company
Sim Analytics Oy relies on strong research expertise. Its story began when three researcher colleagues working in different laboratories at LUT University began to consider how to provide and analyse data in a way that would support industrial companies in making business decisions.
Vertics Oy was born from the vision of two upper secondary school students
Atte Pohjanmaa, who founded a company when he was still an upper secondary school student, succeeded in growing his company even during the coronavirus years.